Management of anemia in children receiving chronic peritoneal dialysis

Journal of the American Society of Nephrology

Volumn 24, Issue 4, 2013, Pages 665-676

  Borzych Duzalka, Dagmara ^a,b   Bilginer, Yelda ^c   Soo Ha, Il ^d   Bak, Mustafa ^e   Rees, Lesley ^f   Cano, Francisco ^g   Loza Munarriz, Reyner ^h   Chua, Annabelle ⁱ   Pesle, Silvia ^j   Emre, Sevinc ^k   Urzykowska, Agnieszka ^l   Quiroz, Lily ^m   Ruscasso, Javier Darío ⁿ   White, Colin ^o   Pape, Lars ^p   Ramela, Virginia ^q   Printza, Nikoleta ^r   Vogel, Andrea ^s   Kuzmanovska, Dafina ^t   Simkova, Eva ^u   Müller Wiefel, Dirk E ^v   Sander, Anja ^w   Warady, Bradley A ^x   Schaefer, Franz ^a   more..

^a Center for Pediatrics and Adolescent Medicine   (Germany)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Seoul National University Children's Hospital   (South Korea)

^e Behçet Uz Education and Research Hospital   (Turkey)

^f GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^g HOSPITAL LUIS CALVO MACKENNA   (Chile)

^h HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

ⁱ TEXAS CHILDREN S HOSPITAL   (United States)

^j Hospital Pediátrico Dr H J Notti of Mendoza   (Argentina)

^k ISTANBUL UNIVERSITY   (Turkey)

^l CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^m HOSPITAL ROBERTO DEL RÍO   (Chile)

ⁿ Hospital de Ninos Sor Maria Ludovica   (Argentina)

^o BC CHILDREN S HOSPITAL   (Canada)

^p HANNOVER MEDICAL SCHOOL   (Germany)

^q SENNIAD   (Uruguay)

^r ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^s PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^t Nephrology Unit   (Macedonia)

^u DUBAI HOSPITAL   (United Arab Emirates)

^v UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^w UNIVERSITY OF HEIDELBERG   (Germany)

^x CHILDREN S MERCY HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERRITIN; HEMOGLOBIN; PARATHYROID HORMONE; PERITONEAL DIALYSIS FLUID;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; ASIA; BODY SURFACE; CHILD; CLINICAL PRACTICE; DIURESIS; DRUG EFFICACY; EUROPE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL; THERAPY EFFECT; TREATMENT OUTCOME; TURKEY (REPUBLIC); URINE VOLUME;

EID: 84875724009     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012050433     Document Type: Article

References (39)

1. McMahon LP, Mason K, Skinner SL, Burge CM, Grigg LE, Becker GJ: Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure.Nephrol Dial Transplant 15: 1425-1430, 2000
2. Fink J, Blahut S, Reddy M, Light P: Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37: 348-355, 2001
3. Warady BA, Ho M: Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 18: 1055-1062, 2003
4. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with lowhematocrit values in patients with cardiac diseasewho are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590, 1998
5. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S,Wolfson M, Reddan D; CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006
6. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, ParvingHH, RemuzziG, Singh AK, Solomon SD, Toto R, Uno H; TREAT Investigators: Baseline characteristics in the trial to reduce cardiovascular events with Aranesp therapy (TREAT). Am J Kidney Dis 54: 59-69, 2009
7. Chesney RW, Brewer E, Moxey-Mims M, Watkins S, Furth SL, Harmon WE, Fine RN, Portman RJ, Warady BA, Salusky IB, Langman CB, Gipson D, Scheidt P, Feldman H, Kaskel FJ, Siegel NJ: Report of an NIH task force on research priorities in chronic kidney disease in children. Pediatr Nephrol 21: 14-25, 2006
8. Pattaragarn A, Warady BA, Sabath RJ: Exercise capacity in pediatric patients with end-stage renal disease. Perit Dial Int 24: 274-280, 2004
9. Gerson A, HwangW, Fiorenza J, Barth K, Kaskel F, Weiss L, Zelikovsky N, Fivush B, Furth S: Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis 44: 1017-1023, 2004
10. Glader B: The Anemias. In: Nelson Textbook of Pediatrics, edited by Kliegman RM, Jenson HB, Behrman RE, Stanton BF, 18th Ed., Philadelphia, Saunders, 2007, pp 2003-2006
11. Ho M, Stablein DM: North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 2003 annual report, Rockville, MD, The EMMES Corporation, 2003
12. Lai KN, Leung JC: Inflammation in peritoneal dialysis. Nephron Clin Pract 116: c11-c18, 2010
13. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, GahlGM, Frei U, Passlick-Deetjen J, Jörres A: Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 12: 2434-2441, 2001
14. Noh H, KimJS, Han KH, Lee GT, Song JS, Chung SH, Jeon JS, Ha H, Lee HB: Oxidative stress during peritoneal dialysis: Implications in functional and structural changes in the membrane. Kidney Int 69: 2022-2028, 2006
15. Cooker LA, Luneburg P, Holmes CJ, Jones S, Topley N: Bicarbonate/ Lactate Study Group. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate based peritoneal solutions. Perit Dial Int 21: S102-S107, 2001
16. Rao DS, Shih MS, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328: 171-175, 1993
17. Belsha CW, Berry PL: Effect of hyperparathyroidism on response to erythropoietin in children on dialysis. Pediatr Nephrol 12: 298-303, 1998
18. Gallieni M, Corsi C, Brancaccio D: Hyperparathyroidism and anemia in renal failure. Am J Nephrol 20: 89-96, 2000
19. Kalantar-Zadeh K, Lee GH, Miller JE, Streja E, Jing J, Robertson JA, Kovesdy CP: Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. AmJ Kidney Dis 53: 823-834, 2009
20. Brancaccio D, Cozzolino M, Gallieni M: Hyperparathyroidism and anemia in uremic subjects: A combined therapeutic approach. J Am Soc Nephrol 15[Suppl 1]: S21-S24, 2004
21. Şahin G, Acikalin MF, Yalcin AU: Erythropoietin resistance as a result of oxalosis in bone marrow. Clin Nephrol 63: 402-404, 2005
22. Milford DV, Winterborn MH: Resistance to recombinant human erythropoietin in a child with renal failure, cystinosis and beta-thalassaemia minor. Nephron 64: 645-646, 1993
23. Palis J, Segel GB: Developmental biology of erythropoiesis. Blood Rev 12: 106-114, 1998
24. Rodriguez W, Selen A, Avant D, Chaurasia C, Crescenzi T, Gieser G, Di Giacinto J, Huang SM, Lee P, Mathis L, Murphy D, Murphy S, Roberts R, Sachs HC, Suarez S, Tandon V, Uppoor RS: Improving pediatric dosing through pediatric initiatives: What we have learned. Pediatrics 121: 530-539, 2008
25. Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter DJ: Epoetin requirements predictmortality in hemodialysis patients. Am J Kidney Dis 44: 866-876, 2004
26. Szczech LA, Barnhart HX, Inrig JK, Reddan DN, Sapp S, Califf RM, Patel UD, Singh AK: Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int 74: 791-798, 2008
27. Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JJ, Pfeffer MA; Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Investigators: Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 363: 1146-1155, 2010
28. Smith KJ, Bleyer AJ, Little WC, Sane DC: The cardiovascular effects of erythropoietin. Cardiovasc Res 59: 538-548, 2003
29. Vaziri ND, Zhou XJ: Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease. Nephrol Dial Transplant 24: 1082-1088, 2009
30. Morakkabati N, Gollnick F, Meyer R, Fandrey J, Jelkmann W: Erythropoietin induces Ca2+mobilization and contraction in rat mesangial and aortic smooth muscle cultures. Exp Hematol 24: 392-397, 1996
31. Goodkin DA, Fuller DS, Robinson BM, Combe C, Fluck R, Mendelssohn D, Akizawa T, Pisoni RL, Port FK:Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol 22: 358-365, 2011
32. Hero M, Wickman S, Hanhijärvi R, Siimes MA, Dunkel L: Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen. J Pediatr 146: 245-252, 2005
33. Borzych D, Bakkaloglu SA, Zaritsky J, Suarez A, Wong W, Ranchin B, Qi C, Szabo AJ, Coccia PA, Harambat J, Mitu F, Warady BA, Schaefer F; International Pediatric Peritoneal Dialysis Network: Defining left ventricular hypertrophy in children on peritoneal dialysis. Clin J Am Soc Nephrol 6: 1934-1943, 2011
34. Bakkaloglu SA, Borzych D, Soo Ha I, Serdaroglu E, Büscher R, Salas P, Patel H, Drozdz D, Vondrak K, Watanabe A, Villagra J, Yavascan O, Valenzuela M, Gipson D, Ng KH, Warady BA, Schaefer F; International Pediatric Peritoneal Dialysis Network: Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry. Clin J Am Soc Nephrol 6: 1926-1933, 2011
35. Warady BA, Arar MY, Lerner G, Nakanishi AM, Stehman-Breen C: Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatr Nephrol 21: 1144-1152, 2006
36. The National Clinical Guideline Centre Anaemia management in people with chronic kidney disease: NICE guidance. May 30, 2012. Available at: http://guidance.nice.org.uk/CG114/NICEGuidance/pdf/English
37. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57: 450-458, 1986
38. Lauer MS, Anderson KM, Larson MG, Levy D: A new method for indexing left ventricular mass for differences in body size. Am J Cardiol 74: 487-491, 1994
39. Khoury PR, Mitsnefes M, Daniels SR, Kimball TR: Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22: 709-714, 2009